Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

The CXCL9 Polymorphism rs884304 Associates with Early CXCL9 Reconstitution and with Severe Chronic Graft-Versus-Host Disease (cGVHD) in Human Allograft Recipients

Hao Dai, Sivaramakrishna P. Rachakonda, PhD, Olaf Penack, MD, Aleksandar Radujkovic, MD, Carsten Müller-Tidow, MD, Rajiv Kumar, PhD, Peter Dreger, Thomas Luft, MD PhD

Blood (2019) 134 (Supplement_1): 873.

https://doi.org/10.1182/blood-2019-124742

Published: 2019

Journal Articles

Early Hyperbilirubinemia Is an Independent Predictor of Outcome after Allogeneic Stem Cell Transplantation and Correlates with Markers of Endothelial Cell Dysfunction

Thomas Luft, MD PhD, Hao Dai, Aleksandar Radujkovic, MD, David Schult, Joshua Majer-Lauterbach, Olga Blau, MD PhD, Lars Bullinger, Sihe Jiang, Carsten Müller-Tidow, MD, Peter Dreger, Olaf Penack, MD

Blood (2019) 134 (Supplement_1): 4487.

https://doi.org/10.1182/blood-2019-124284

Published: 2019

Journal Articles

From Ex-Vivo T-Cell Depletion to Post-Transplant Cyclophosphamide: Improved GvHD-Free & Relapse-Free Survival but Comparable Chronic GvHD Incidence in Haploidentical Transplantation. A 15 Years EBMT Registry Analysis on Behalf of the TCWP-EBMT

Maria Teresa Lupo-Stanghellini, MD, Christophe Peczynski, Hildegard T. Greinix, MD, Emmanuelle Polge, Mohamad Mohty, MD PhD, Ibrahim Yakoub-Agha, MD PhD, Silvia Montoto, MD, Nicolaus Kröger, MD, Zinaida Peric, MD PhD, Olaf Penack, MD, Rafael F Duarte, MDPhDFRCP, Grzegorz W Basak, MD PhD Professor

Blood (2019) 134 (Supplement_1): 876.

https://doi.org/10.1182/blood-2019-129105

Published: 2019

Journal Articles

Genetic Risk of Severe Chronic Graft-Versus-Host Disease Defined By Host-Derived CXCR3 Ligands

Hao Dai, Sivaramakrishna P. Rachakonda, PhD, Olaf Penack, MD, Aleksandar Radujkovic, MD, Carsten Müller-Tidow, MD, Olga Blau, MD PhD, Igor-Wolfgang Blau, MD PhD, Rajiv Kumar, PhD, Peter Dreger, Thomas Luft, MD PhD

Blood (2018) 132 (Supplement 1): 357.

https://doi.org/10.1182/blood-2018-99-113820

Published: 2018

Journal Articles

Incidence of Acute Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation over Time: A Study from the Transplant Complications and Chronic Malignancies Working Party of the EBMT

Blood (2018) 132 (Supplement 1): 2120.

https://doi.org/10.1182/blood-2018-99-111764

Published: 2018

Journal Articles

Evaluation of Clinical and Morphological Practices in the Diagnosis of Transplant-Associated Microangiopathy: A Study on Behalf of the Complications and Quality of Life Working Party of the EBMT

Blood (2017) 130 (Supplement 1): 1958.

https://doi.org/10.1182/blood.V130.Suppl_1.1958.1958

Published: 2017

Journal Articles

Mortality after Allogeneic Stem Cell Transplantation Associates with Gene Polymorphisms in CD40L and Thrombomodulin in the Absence of Statins

Thomas Luft, MD PhD, Sivaramakrishna P. Rachakonda, PhD, Hao Dai, Olaf Penack, MD, Olga Blau, Igor Wolfgang Blau, MD, Aleksandar Radujkovic, MD, Carsten Müller-Tidow, Peter Dreger, MD, Rajive Kumar, PhD

Blood (2017) 130 (Supplement 1): 3244.

https://doi.org/10.1182/blood.V130.Suppl_1.3244.3244

Published: 2017

Journal Articles

It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)

Thomas Luft, MD PhD, Axel Benner, Sonata Jodele, MD, Christopher E. Dandoy, MD, Rainer F. Storb, MD, Ted A. Gooley, PhD, Brenda M. Sandmaier, MD, Aleksandar Radujkovic, MD, Anthony D. Ho, MD, Peter Dreger, MD, Olaf Penack, MD

Blood (2016) 128 (22): 519.

https://doi.org/10.1182/blood.V128.22.519.519

Published: 2016

Journal Articles

Initiation of Acute Graft-Versus-Host Disease By Angiogenesis

Katarina Riesner, Yu Shi, Angela Jacobi, Martin Kraeter, Martina Kalupa, Aleixandria McGearey, Sarah Mertlitz, Steffen Cordes, Jens-Florian Schrezenmeier, Joerg Mengwasser, Sabine Westphal, Daniel Perez-Hernandez, Clemens Schmitt, Gunnar Dittmar, Jochen Guck, Olaf Penack, MD

Blood (2016) 128 (22): 4533.

https://doi.org/10.1182/blood.V128.22.4533.4533

Published: 2016

Journal Articles

Efficacy of Adoptive Immunotherapy By Donor Lymphocyte Infusions after Allogeneic Stem Cell Transplantation from Related an Unrelated Donors: A Single Center Retrospective Analysis

Philipp Hemmati, MD, Christin Vogelsänger, Theis Terwey, MD, Christian Jehn, MD, Lam G. Vuong, MD PhD, Igor Wolfgang Blau, MD, Olaf Penack, MD, Bernd Dörken, Renate Arnold, MD PhD

Blood (2016) 128 (22): 4556.

https://doi.org/10.1182/blood.V128.22.4556.4556

Published: 2016

Journal Articles

Single Nucleotide Polymorphisms Within The Thrombomodulin Gene (THBD) Predict Risk Of Non-Relapse Mortality In Patients With Graft-Versus-Host Disease

Thomas Luft, MD, PhD, Olaf Penack, MD, Olga Blau, MD, PhD, Sascha Dietrich, MD, Berend H. Isermann, MD, Anthony D Ho, MD, Lutz Uharek, Peter Dreger, MD, Rajive Kumar, PhD, Krishna P.S. Rachakonda, PhD

Blood (2013) 122 (21): 4589.

https://doi.org/10.1182/blood.V122.21.4589.4589

Published: 2013

Journal Articles

Allogeneic Stem Cell Transplantation In Adults With High Risk Acute Lymphoblastic Leukemia (ALL) In 1. Remission (CR1): Promising, But Strongly Influenced By ALL Subtypes

Renate Arnold, MD, Theis H. Terwey, MD, Giang Lam Vuong, MD, Benjamin Ostendorf, MD, Olaf Penack, MD, Gero Massenkeil, MD, Nicola Gökbuget, MD, Philipp Hemmati, MD

Blood (2013) 122 (21): 3409.

https://doi.org/10.1182/blood.V122.21.3409.3409

Published: 2013

Journal Articles

Close To Clinics: Acute Gvhd In a Novel Chemotherapy Based Minor Mismatch Transplantation Model

Katarina Riesner, Martina Kalupa, Steffen Cordes, Sefer Elezkurtaj, Karen Grossmann, Sandra Rudloff, Yu Shi, Sabine Westphal, Andrea Wilke, Jörg Mengwasser, Olaf Penack, MD

Blood (2013) 122 (21): 5420.

https://doi.org/10.1182/blood.V122.21.5420.5420

Published: 2013

Journal Articles

Adult Patients with Hemophagocytic Lymphohistiocytosis (HLH) in Germany: A Retrospective Multicenter Case Study of 29 Patients

Thomas Schenk, MD, Georg Maschmeyer, MD, Frank Rothmann, MD, Thomas Weber, MD, Maximilian Christopeit, MD, Olaf Penack, MD, PhD, Daniela Goy, MD, Jens Panse, MD, Gritta Janka, MD, PhD, Andreas Hochhaus, MD, Paul La Rosee, MD

Blood (2012) 120 (21): 3271.

https://doi.org/10.1182/blood.V120.21.3271.3271

Published: 2012

Journal Articles

Over-Expression of TRAIL on Donor T Cells Enhances GVT and Suppresses Gvhd Via Elimination of Alloreactive T Cells and Host APC

Arnab Ghosh, MD, PhD, Yildirim Dogan, PhD, Amanda M. Holland, BS, Odette M Smith, BA, Lauren F. Young, BS, Mallory L West, BS, Natalie V Singer, BS, Robert R Jenq, MD, Il-Kang Na, MD/PhD, Olaf Penack, MD/PhD, Alan M Hanash, MD, PhD, Martin G. Sauer, MD, Michel Sadelain, MD, PhD, Marcel R.M. van den Brink, MD, PhD

Blood (2011) 118 (21): 817.

https://doi.org/10.1182/blood.V118.21.817.817

Published: 2011

Journal Articles

Genetic Engineering of Donor T Cells for BMT Immunotherapy: Expression of TRAIL and PLZF Selectively Enhances GVT and Abrogates Gvhd

Arnab Ghosh, MD, PhD, Amanda M. Holland, BS, Yildirim Dogan, PhD, Nury Yim, BS, Uttam K. Rao, BA, Lauren F. Young, BS, Odette M. Smith, BA, Robert Jenq, MD, Il-Kang Na, MD/PhD, Jennifer Tsai, MD, Olaf Penack, MD/PhD, Alan M. Hanash, MD, PhD, Martin G. Sauer, MD, Derek Sant'Angelo, PhD, Michel Sadelain, MD, PhD, Marcel R.M. van den Brink, MD, PhD

Blood (2010) 116 (21): 730.

https://doi.org/10.1182/blood.V116.21.730.730

Published: 2010

Journal Articles

TRAIL/ DR5 Interactions Are Important for Thymic Damage After Allogeneic Bone Marrow Transplantation.

Blood (2009) 114 (22): 234.

https://doi.org/10.1182/blood.V114.22.234.234

Published: 2009

Journal Articles

P-Selectin in Recipients of Allogeneic Bone Marrow Transplantation Regulates Experimental Graft-Versus-Host-Disease.

Sydney X Lu, PhD, Maria Lia Palomba, MD, Il-Kang Na, MD, Theis Terwey, Onder Alpdogan, MD, Jhoanne L Bautista, Marsinay O Smith, David Suh, Christopher King, Uttam Rao, Nury Yim, Robert R. Jenq, MD, Johannes L Zakrzewski, MD, Amanda M. Holland, Olaf Penack, MD, Lindsay Dykstra, Kevin Bampoe, Marcel R.M. van den Brink, MD, PhD

Blood (2009) 114 (22): 1335.

https://doi.org/10.1182/blood.V114.22.1335.1335

Published: 2009

Journal Articles

The T Cell Cytolytic Molecules Fas Ligand and TRAIL, the Trafficking Molecules CCR9, β7 Integrin and PSGL-1, and the Immune Modulating Molecules OX40, CEACAM1, and CTLA4 Are Required for Thymic Graft-Versus-Host Disease

Blood (2008) 112 (11): 65.

https://doi.org/10.1182/blood.V112.11.65.65

Published: 2008

Journal Articles

Low Dose Liposomal Amphotericin B (L-AmB) as Prophylaxis of Invasive Fungal Infections (IFI) in Neutropenic Patients (pts): Is It Cost Effective?.

Olaf Penack, MD, Peter Martus, PhD, Eckhard Thiel, MD, Igor W. Blau, MD

Blood (2006) 108 (11): 3324.

https://doi.org/10.1182/blood.V108.11.3324.3324

Published: 2006

NARROW

The CXCL9 Polymorphism rs884304 Associates with Early CXCL9 Reconstitution and with Severe Chronic Graft-Versus-Host Disease (cGVHD) in Human Allograft Recipients

Early Hyperbilirubinemia Is an Independent Predictor of Outcome after Allogeneic Stem Cell Transplantation and Correlates with Markers of Endothelial Cell Dysfunction

From Ex-Vivo T-Cell Depletion to Post-Transplant Cyclophosphamide: Improved GvHD-Free & Relapse-Free Survival but Comparable Chronic GvHD Incidence in Haploidentical Transplantation. A 15 Years EBMT Registry Analysis on Behalf of the TCWP-EBMT

Genetic Risk of Severe Chronic Graft-Versus-Host Disease Defined By Host-Derived CXCR3 Ligands

Incidence of Acute Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation over Time: A Study from the Transplant Complications and Chronic Malignancies Working Party of the EBMT

Evaluation of Clinical and Morphological Practices in the Diagnosis of Transplant-Associated Microangiopathy: A Study on Behalf of the Complications and Quality of Life Working Party of the EBMT

Mortality after Allogeneic Stem Cell Transplantation Associates with Gene Polymorphisms in CD40L and Thrombomodulin in the Absence of Statins

It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)

Initiation of Acute Graft-Versus-Host Disease By Angiogenesis

Efficacy of Adoptive Immunotherapy By Donor Lymphocyte Infusions after Allogeneic Stem Cell Transplantation from Related an Unrelated Donors: A Single Center Retrospective Analysis

Single Nucleotide Polymorphisms Within The Thrombomodulin Gene (THBD) Predict Risk Of Non-Relapse Mortality In Patients With Graft-Versus-Host Disease

Allogeneic Stem Cell Transplantation In Adults With High Risk Acute Lymphoblastic Leukemia (ALL) In 1. Remission (CR1): Promising, But Strongly Influenced By ALL Subtypes

Close To Clinics: Acute Gvhd In a Novel Chemotherapy Based Minor Mismatch Transplantation Model

Adult Patients with Hemophagocytic Lymphohistiocytosis (HLH) in Germany: A Retrospective Multicenter Case Study of 29 Patients

Over-Expression of TRAIL on Donor T Cells Enhances GVT and Suppresses Gvhd Via Elimination of Alloreactive T Cells and Host APC

Genetic Engineering of Donor T Cells for BMT Immunotherapy: Expression of TRAIL and PLZF Selectively Enhances GVT and Abrogates Gvhd

TRAIL/ DR5 Interactions Are Important for Thymic Damage After Allogeneic Bone Marrow Transplantation.

P-Selectin in Recipients of Allogeneic Bone Marrow Transplantation Regulates Experimental Graft-Versus-Host-Disease.

The T Cell Cytolytic Molecules Fas Ligand and TRAIL, the Trafficking Molecules CCR9, β7 Integrin and PSGL-1, and the Immune Modulating Molecules OX40, CEACAM1, and CTLA4 Are Required for Thymic Graft-Versus-Host Disease

Low Dose Liposomal Amphotericin B (L-AmB) as Prophylaxis of Invasive Fungal Infections (IFI) in Neutropenic Patients (pts): Is It Cost Effective?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only